Stay updated on SL-401 in BPDCN or AML Clinical Trial
Sign up to get notified when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.

Latest updates to the SL-401 in BPDCN or AML Clinical Trial page
- Check6 days agoChange DetectedThe page shows a revision bump from v3.5.3 to v3.5.4, representing a minor update to the site. The study content and links remain unchanged.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe revision tag on the page was updated from v3.5.2 to v3.5.3, signaling an updated version of the study documents.SummaryDifference0.1%

- Check27 days agoChange DetectedNo detectable content changes were provided.SummaryDifference0.0%

- Check35 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded CD4+/CD56+ hematodermic neoplasm as an additional MeSH term for the study.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to SL-401 in BPDCN or AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.